COMMENT

Statistical pitfalls of personalized medicine

Misleading terminology and arbitrary divisions stymie drug trials and can give false hope about the potential of tailoring drugs to individuals, warns Stephen Senn.
Stephen Senn was formerly head of the Competence Center for Methodology and Statistics at the Luxembourg Institute of Health.
Contact

Search for this author in:

Illustration by David Parkins

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

Nature 563, 619-621 (2018)

doi: 10.1038/d41586-018-07535-2

References

  1. 1.

    Schork, N. J. Nature 520, 609–611 (2015).

  2. 2.

    Marquat, J., Chen, E. Y. & Prasad, V. JAMA Oncol. 4, 1093–1098 (2018).

  3. 3.

    Labenz, J. et al. Aliment. Pharmacol. Ther. 21, 739–746 (2005).

  4. 4.

    Gralnek, I. M., Dulai, G. S., Fennerty, M. B. & Spiegel, B. M. Clin. Gastroenterol. Hepatol. 4, 1452–1458 (2006).

  5. 5.

    Fedorov, V., Mannino, F. & Zhang, R. Pharm. Stat. 8, 50–61 (2009).

  6. 6.

    Senn, S. Stat. Biopharm. Res. 5, 204–210 (2013).

  7. 7.

    Senn, S. Br. Med. J. 329, 966–968 (2004).

  8. 8.

    Laupacis, A., Sackett, D. L. & Roberts, R. S. N. Engl. J. Med. 318, 1728–1733 (1988).

  9. 9.

    Portenoy, R. K., Burton, A. W., Gabrail, N., Taylor, D. & Fentanyl Pectin Nasal Spray 043 Study Group. Pain 151, 617–624 (2010).

  10. 10.

    Wegman, A. C. et al. Fam. Pract. 22, 152–159 (2005).

  11. 11.

    Araujo, A., Julious, S. & Senn, S. PLoS ONE 11, e0167167 (2016).

  12. 12.

    Senn, S. Stat. Med. 35, 966–977 (2016).

Download references

Nature Briefing

Sign up for the daily Nature Briefing email newsletter

Stay up to date with what matters in science and why, handpicked from Nature and other publications worldwide.

Sign Up